Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
13.09
-0.50 (-3.68%)
At close: Aug 1, 2025, 4:00 PM
13.05
-0.04 (-0.31%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Precision Medicine | 771.11M | Log In | Log In | Log In | Log In | Upgrade |
Therapeutics | 9.35M | Log In | Log In | Log In | Log In | Upgrade |
Manufacturing Solutions | 2.75M | Log In | Log In | Log In | Log In | Upgrade |
Commercial | - | Log In | Log In | Log In | Log In | Upgrade |
Commercial Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Product Development | - | Log In | Log In | Log In | Log In | Upgrade |
Product Development Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Molecularly Targeted Radiation | - | Log In | Log In | Log In | Log In | Upgrade |
Molecularly Targeted Radiation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
United States | 762.31M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 55.68% | Log In | Log In | Log In | Log In | Upgrade |
Other Countries | 16.01M | Log In | Log In | Log In | Log In | Upgrade |
Other Countries Growth | 242.94% | Log In | Log In | Log In | Log In | Upgrade |
Canada | 2.54M | Log In | Log In | Log In | Log In | Upgrade |
Australia | 1.22M | Log In | Log In | Log In | Log In | Upgrade |
Australia Growth | 4.63% | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom | 579.00K | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom Growth | -55.67% | Log In | Log In | Log In | Log In | Upgrade |
Belgium | 546.00K | Log In | Log In | Log In | Log In | Upgrade |
Belgium Growth | 19.21% | Log In | Log In | Log In | Log In | Upgrade |
China | - | Log In | Log In | Log In | Log In | Upgrade |
China Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Austria | - | Log In | Log In | Log In | Log In | Upgrade |
Australia, United States, Belgium and Japan | - | Log In | Log In | Log In | Log In | Upgrade |
Australia, United States, Belgium and Japan Growth | - | Log In | Log In | Log In | Log In | Upgrade |